Document is current
Any future updates will be listed below
-
Authors
Widding, Jeppe Lyngbye https://orcid.org/0009-0008-8736-7724
Stroomberg, Hein Vincent https://orcid.org/0000-0002-7293-9506
Dalton, Susanne Oksbjerg
Brasso, Klaus
Røder, Andreas
Larsen, Signe Benzon
-
Funding
Funding for this research was provided by:
Kræftens Bekæmpelse (R328A19006)
Kirsten og Freddy Johansens Fond
- License Information
-
More Information
Article History
Received: 22 May 2025
Revised: 28 October 2025
Accepted: 14 November 2025
First Online: 3 December 2025
Competing interests
: HVS has received travel expenses and speaking and lecture fees from MSD Denmark, and project support from Pfizer Denmark outside of the scope of this manuscript. KB has received speaker fees from Bayer Denmark outside the scope of this manuscript. AR has received project support from Bayer Denmark and Pfizer Denmark, prior speaker fee from Astellas Nordic, and advisory and consultancy for Pfizer, Amgen, MSD, Sanofi, Janssen, Astra-Zeneca, Recordati, Astellas, Bayer, Orion, Ferrin, Medtronic, and Intuitive outside of the scope of this manuscript.
: The present study was performed in accordance with the Declaration of Helsinki. It was based on anonymized, centrally located Danish national register data, and approvals by relevant authorities have been obtained: Usage of DanProst by Danish Patient Safety Authority (Journal-nr.: 31-1521-330), creation and approval of the project at Statistic Denmark (Project nr.: 708122), and Danish Health Data Authority (Prescription Registry) (FEID-00005346).
